Takeda pays InSilico to make use of its proprietary Pharma. AI platform to advance drug candidates throughout a number of therapeutic areas.
Source link
Takeda, InSilico Strike AI Drug-Discovery Deal Worth Up to $600 Million
Related Posts
ElevenLabs targets $6B valuation in employee secondary sale — TFN
ElevenLabs, an AI voice startup founded in 2022, is on track for a $6 billion valuation following an employee secondary…
Oracle Cloud to deploy 50,000 AMD AI chips as alternative to Nvidia
Oracle Cloud Infrastructure on Tuesday introduced it is going to deploy 50,000 Advanced Micro Devices graphics processors beginning within the…
Identity, Data Security Converging Into Trouble for Security Teams: Report
A brand new Netwrix report warns that converging identification and knowledge safety, mixed with AI-driven automation, is increasing assault surfaces…